We have so many candidates for President, declared and undeclared, that they follow fairly conventional distributions on many traits. For example, how many have had cancer? Sen. John McCain was diagnosed with malignant melanoma in 2000 (Celtic ancestry and Arizona sunshine can be a bad combination).
Actor and undeclared candidate Fred Thompson has a (currently) incurable form of slow-acting (or “indolent”) lymphoma (cancer of the lymphatic system), in contrast to the more aggressive lymphomas which offer more of a high stakes gamble — they can kill you quick or be cured. (I was treated for intermediate grade lymphoma in 1997.)
When a tumor showed up under his jaw in 2004, Thompson had it treated first with radiation, which often doesn’t work as well with lymphoma as with other cancers because lymphoma tends to be diffused rather than just in one place where you can zap it.
Then he was treated with Rituxan, a monoclonal antibody that inspires the body’s own immune system to target the cancer cells. It’s often compared to smart bombs, while standard chemotherapy is compared to Dresden-style carpet bombing in which you try to kill everything that’s growing in you in the hope that you can kill the cancer before you kill yourself.
(In 1997, I was, I believe, the first person in the world with intermediate-grade [moderately fast growing] lymphoma to be treated with Rituxan. I’m still here and Rituxan had sales of $1.6 billion in 2004 in the U.S. alone. The standard treatment for aggressive lymphoma is today CHOP chemotherapy and Rituxan, which I was fortunate enough to get a decade ago. I’m now almost ten years out, so the odds of avoiding a relapse look good for me, knock on wood.)
Thompson is currently in remission. Many people his age, 64, will die of old age before his slow-acting kind of lymphoma kills them. He is fairly likely to relapse, however, if he otherwise stays in good health. He claims that another round of treatment, if it became necessary, wouldn’t be “debilitating.”
- doing nothing until the pain gets bad (watch-and-wait)
- to radiation therapy
- to more Rituxan, which doesn’t have many side effects
- to the two second-generation monoclonal antibodies for lymphoma, Zevalin and Bexxar, that come loaded with radioactive substances to deliver radiation right to the cancer cells. These have more side effects, but still aren’t as bad as chemotherapy.
- to traditional chemotherapy (which many people, including me, find debilitating — I didn’t suffer much nausea, but slept 12 hours per day during my 18 weeks of treatment and suffered anemia for about a year afterwards)
- to intensive chemotherapy, which is usually called a stem-cell transplant or bone marrow transplant. It’s no fun.
It would be useful if an oncologist would calculate the odds for us that Thompson could get through both one and two four-year terms as President without having to resort to debilitating treatments for relapses. I would guess that he’d probably get through a single term okay, but I wouldn’t begin to guess about two terms. And don’t listen to me, anyway.
In general, the U.S. has been lucky with the health of its Presidents, even though the press wasn’t very responsible about reporting the facts to voters. FDR managed to survive long enough until Harry Truman had replaced Stalin-fan Henry Wallace as Vice-President, and Reagan’s old-age deterioration didn’t come with major costs. Oddly, the most nearly disastrous health problems were those of the youngest elected President, JFK, who was in a lot of pain much of his life. He was so pilled-up and unimpressive when he first met Khrushchev in Vienna in 1961 that the Soviet supremo thought he could push the playboy around over missiles in Cuba.